chr4-47603404-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_006587.4(CORIN):c.2805C>A(p.Gly935Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00239 in 1,613,732 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 32 hom. )
Consequence
CORIN
NM_006587.4 synonymous
NM_006587.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.36
Publications
2 publications found
Genes affected
CORIN (HGNC:19012): (corin, serine peptidase) This gene encodes a member of the type II transmembrane serine protease class of the trypsin superfamily. Members of this family are composed of multiple structurally distinct domains. The encoded protein converts pro-atrial natriuretic peptide to biologically active atrial natriuretic peptide, a cardiac hormone that regulates blood volume and pressure. This protein may also function as a pro-brain-type natriuretic peptide convertase. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2013]
CORIN Gene-Disease associations (from GenCC):
- preeclampsia/eclampsia 5Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 4-47603404-G-T is Benign according to our data. Variant chr4-47603404-G-T is described in ClinVar as Benign. ClinVar VariationId is 785089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (1718/152194) while in subpopulation AFR AF = 0.0383 (1591/41516). AF 95% confidence interval is 0.0368. There are 32 homozygotes in GnomAd4. There are 808 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 Unknown gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CORIN | ENST00000273857.9 | c.2805C>A | p.Gly935Gly | synonymous_variant | Exon 20 of 22 | 1 | NM_006587.4 | ENSP00000273857.4 |
Frequencies
GnomAD3 genomes AF: 0.0113 AC: 1713AN: 152076Hom.: 31 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1713
AN:
152076
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00374 AC: 930AN: 248368 AF XY: 0.00290 show subpopulations
GnomAD2 exomes
AF:
AC:
930
AN:
248368
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00146 AC: 2140AN: 1461538Hom.: 32 Cov.: 32 AF XY: 0.00125 AC XY: 908AN XY: 727066 show subpopulations
GnomAD4 exome
AF:
AC:
2140
AN:
1461538
Hom.:
Cov.:
32
AF XY:
AC XY:
908
AN XY:
727066
show subpopulations
African (AFR)
AF:
AC:
1324
AN:
33478
American (AMR)
AF:
AC:
85
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
409
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
6
AN:
86244
European-Finnish (FIN)
AF:
AC:
0
AN:
53152
Middle Eastern (MID)
AF:
AC:
10
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
88
AN:
1111964
Other (OTH)
AF:
AC:
218
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
121
241
362
482
603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0113 AC: 1718AN: 152194Hom.: 32 Cov.: 32 AF XY: 0.0109 AC XY: 808AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
1718
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
808
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
1591
AN:
41516
American (AMR)
AF:
AC:
43
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
58
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10
AN:
68022
Other (OTH)
AF:
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
83
166
250
333
416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.